161 related articles for article (PubMed ID: 26716870)
1. Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal.
Li X; Guo Y; Yan W; Snyder MP; Li X
PLoS One; 2015; 10(12):e0146152. PubMed ID: 26716870
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes.
Zinman B; Haffner SM; Herman WH; Holman RR; Lachin JM; Kravitz BG; Paul G; Jones NP; Aftring RP; Viberti G; Kahn SE;
J Clin Endocrinol Metab; 2010 Jan; 95(1):134-42. PubMed ID: 19875477
[TBL] [Abstract][Full Text] [Related]
3. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
Maheshwari RA; Balaraman R; Sen AK; Seth AK
Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
[TBL] [Abstract][Full Text] [Related]
4. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
5. Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism.
Scheidemantle G; Duan L; Lodge M; Cummings MJ; Hilovsky D; Pham E; Wang X; Kennedy A; Liu X
Metabolomics; 2024 May; 20(3):53. PubMed ID: 38722395
[TBL] [Abstract][Full Text] [Related]
6. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
7. Scutellaria baicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic Wistar rats.
Waisundara VY; Hsu A; Huang D; Tan BK
Am J Chin Med; 2008; 36(3):517-40. PubMed ID: 18543386
[TBL] [Abstract][Full Text] [Related]
8. Assessment of genomic instability in normal and diabetic rats treated with metformin.
Attia SM; Helal GK; Alhaider AA
Chem Biol Interact; 2009 Jul; 180(2):296-304. PubMed ID: 19497428
[TBL] [Abstract][Full Text] [Related]
9. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice.
Yu JW; Deng YP; Han X; Ren GF; Cai J; Jiang GJ
Cardiovasc Diabetol; 2016 Jun; 15():88. PubMed ID: 27316923
[TBL] [Abstract][Full Text] [Related]
10. Immediate reduction of serum citrulline but no change of steroid profile after initiation of metformin in individuals with type 2 diabetes.
Breier M; Wahl S; Prehn C; Ferrari U; Sacco V; Weise M; Grallert H; Adamski J; Lechner A
J Steroid Biochem Mol Biol; 2017 Nov; 174():114-119. PubMed ID: 28801099
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of metformin in diabetes-related bone disease].
Kanazawa I
Clin Calcium; 2009 Sep; 19(9):1319-25. PubMed ID: 19721204
[TBL] [Abstract][Full Text] [Related]
12. Anti-diabetic activities of Acanthopanax senticosus polysaccharide (ASP) in combination with metformin.
Fu J; Fu J; Yuan J; Zhang N; Gao B; Fu G; Tu Y; Zhang Y
Int J Biol Macromol; 2012 Apr; 50(3):619-23. PubMed ID: 22326821
[TBL] [Abstract][Full Text] [Related]
13. Changes and Significance of Central Carbon Metabolism before and after Metformin Treatment of Type 2 Diabetes Based on Mass Spectrometry.
Shu Y; Yang F; Li W; Li L; Hu Q; Xiong D
Discov Med; 2024 Apr; 36(183):678-689. PubMed ID: 38665017
[TBL] [Abstract][Full Text] [Related]
14. Antihyperglycemic mechanism of metformin occurs via the AMPK/LXRα/POMC pathway.
Cho K; Chung JY; Cho SK; Shin HW; Jang IJ; Park JW; Yu KS; Cho JY
Sci Rep; 2015 Jan; 5():8145. PubMed ID: 25634597
[TBL] [Abstract][Full Text] [Related]
15. Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metformin.
Tolosa MJ; Chuguransky SR; Sedlinsky C; Schurman L; McCarthy AD; Molinuevo MS; Cortizo AM
Diabetes Res Clin Pract; 2013 Aug; 101(2):177-86. PubMed ID: 23806481
[TBL] [Abstract][Full Text] [Related]
16. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice.
Zhou J; Xu G; Yan J; Li K; Bai Z; Cheng W; Huang K
J Ethnopharmacol; 2015 Apr; 164():229-38. PubMed ID: 25698243
[TBL] [Abstract][Full Text] [Related]
17. Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride.
Huo T; Cai S; Lu X; Sha Y; Yu M; Li F
J Pharm Biomed Anal; 2009 May; 49(4):976-82. PubMed ID: 19249171
[TBL] [Abstract][Full Text] [Related]
18. Effect of metformin on the urinary metabolites of diet-induced-obese mice studied by ultra performance liquid chromatography coupled to time-of-flight mass spectrometry (UPLC-TOF/MS).
Zhu Y; Feng Y; Shen L; Xu D; Wang B; Ruan K; Cong W
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():110-6. PubMed ID: 23523884
[TBL] [Abstract][Full Text] [Related]
19. Effects of insulin-like growth factor I on alveolar bone remodeling in diabetic rats.
Fang Y; Wang LP; Du FL; Liu WJ; Ren GL
J Periodontal Res; 2013 Apr; 48(2):144-50. PubMed ID: 22834984
[TBL] [Abstract][Full Text] [Related]
20. db/+ Mice as an alternate model in antidiabetic drug discovery research.
Tamrakar AK; Singh AB; Srivastava AK
Arch Med Res; 2009 Feb; 40(2):73-8. PubMed ID: 19237015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
